Schedule 13G ownership disclosure
Arbutus Biopharma Corp
Common Shares · CUSIP: 03879J100
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Morgan Stanley
Shares: 25,910,337 · Class: 13.5%
- Morgan Stanley Investment Management Inc.
Shares: 25,647,127 · Class: 13.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-26-000041
- Form type
- SCHEDULE 13G/A
- Filer
- Arbutus Biopharma Corp
- CIK
- CIK 1447028
- Filed
- Feb 11, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership